Latest news
Loading news…
Eli Lilly
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Indianapolis, Indiana, United States Founded 1876 10001+ employees For Profit
Eli Lilly is a pharma company focused on developing medicines for diabetes, cancer, immunology, and other major health areas.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
51
Investments
137
34 exits
Monthly Visits
Available in Pro Contacts
9,017
Ticker
LLY
NYSE - New York Stock Exchange
Patents
1,970
1,122 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- LLY
- Exchange
- NYSE - New York Stock Exchange
- IPO date
- Jan 13, 1978
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 16
- Mobile apps
- 1
- Active products
- 32
- Patents granted
- 1,970
- Trademarks
- 1,122
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $1B
Investor Activity
- Investments
- 137
- Lead investments
- 33
- Portfolio orgs
- 115
- Diversity investments
- 29
- Exits
- 34
- Exits via IPO
- 20
Company Info
- Founded
- 1876
- Employees
- 10001+
- Operating status
- Active
- Company type
- For Profit
- Org types
- company, investor
- Founders
- 1
- Sub-organizations
- 12
- News articles
- 9,618
- Events
- 3
- HQ
- Indianapolis, Indiana, United States
- Region
- Great Lakes, Midwestern US
- Exit date
- Jan 13, 1978
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.6
- Trend (30d)
- 1.6
- Trend (90d)
- 5.9
- Last leadership hire
- Feb 4, 2026
- Last layoff mention
- Jun 4, 2026
Investments by Eli Lilly
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by Eli Lilly
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Eli Lilly
D
Chief Executive Officer
S
Principal Research Scientist
K
Director
D
Chief Scientific and Product Officer and President
B
IT Collaboration Capabilities Architect
A
Medical Fellow, Clinical Lead
A
Senior Advisor, Consumer Marketing
F
Material Management Technical Support
N
Executive Director, Business Development
A
President, International
S
Manager LRL Medicine Development IT - Regulatory Affairs & Patient Safety
D
Associate Director - Medical Device Development Quality Assurance
T
Sr. Vice President and General Manager
C
TS/MS Consultant, External Manufacturing, Americas
T
Senior Director, Oncology Communications
J
Wholesale Drug Distributor Licensing Consultant
R
Bioprocess Chemist
M
Bioprocess Chemist
T
Senior Vice President and Chief AI Officer
F
Senior Vice President, Global Quality
D
Vice President Global Marketing
E
SVP, Human Resources, and Diversity
D
Senior Director Procurement, Global Research & Development
S
Distinguished Research Fellow
9,017
professional contacts at Eli Lilly
Contact execs at Eli Lilly →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Eli Lilly
Loading news…
FAQs about Eli Lilly
People who checked this page also checked these
Sectors Eli Lilly invests & acquires in
Browse the full Acquirezy directory.